Found: 66
Select item for more details and to access through your institution.
Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00535-1
- By:
- Publication type:
- Article
HIV associated lymphoma: latest updates from 2023 ASH annual meeting.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00532-4
- By:
- Publication type:
- Article
cGAS-ISG15-RAGE axis reprogram necroptotic microenvironment and promote lymphatic metastasis in head and neck cancer.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00531-5
- By:
- Publication type:
- Article
Reconstructed colorectal cancer model to dissect the anti-tumor effect of mesenchymal stromal cells derived extracellular vesicles.
- Published in:
- 2024
- By:
- Publication type:
- Letter
The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00527-1
- By:
- Publication type:
- Article
Tunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I study.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00528-0
- By:
- Publication type:
- Article
High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00524-4
- By:
- Publication type:
- Article
Multi-model analysis of gallbladder cancer reveals the role of OxLDL-absorbing neutrophils in promoting liver invasion.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00521-7
- By:
- Publication type:
- Article
Tunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I study.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00528-0
- By:
- Publication type:
- Article
Advances in nano-immunotherapy for hematological malignancies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00525-3
- By:
- Publication type:
- Article
Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00519-1
- By:
- Publication type:
- Article
Three-dimensional chromatin landscapes in MLLr AML.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00523-5
- By:
- Publication type:
- Article
Correction: ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00517-3
- By:
- Publication type:
- Article
Analysis of CD20 and PD-L1 levels on small extracellular vesicles (sEV) produced by DLBCL cells and EBV-transformed B cells, and potential role in T cell inhibition.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00518-2
- By:
- Publication type:
- Article
Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00520-8
- By:
- Publication type:
- Article
CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00522-6
- By:
- Publication type:
- Article
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00516-4
- By:
- Publication type:
- Article
Single-cell analysis defines highly specific leukemia-induced neutrophils and links MMP8 expression to recruitment of tumor associated neutrophils during FGFR1 driven leukemogenesis.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00514-6
- By:
- Publication type:
- Article
NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00511-9
- By:
- Publication type:
- Article
Enhanced cellular therapy: revolutionizing adoptive cellular therapy.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, p. 1, doi. 10.1186/s40164-024-00506-6
- By:
- Publication type:
- Article
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00515-5
- By:
- Publication type:
- Article
Novel agents and regimens in relapsed or refractory peripheral T-cell lymphoma: latest updates from 2023 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00510-w
- By:
- Publication type:
- Article
Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00508-4
- By:
- Publication type:
- Article
Pan-cancer transcriptional atlas of minimal residual disease links DUSP1 to chemotherapy persistence.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00509-3
- By:
- Publication type:
- Article
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00513-7
- By:
- Publication type:
- Article
Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00512-8
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00505-7
- By:
- Publication type:
- Article
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00503-9
- By:
- Publication type:
- Article
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00504-8
- By:
- Publication type:
- Article
Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11b<sup>high</sup>CD27<sup>low</sup> memory-like NK cells.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00502-w
- By:
- Publication type:
- Article
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00501-x
- By:
- Publication type:
- Article
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00499-2
- By:
- Publication type:
- Article
Heat-killed Prevotella intermedia promotes the progression of oral squamous cell carcinoma by inhibiting the expression of tumor suppressors and affecting the tumor microenvironment.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00500-y
- By:
- Publication type:
- Article
Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer metastasis.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00497-4
- By:
- Publication type:
- Article
Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00498-3
- By:
- Publication type:
- Article
Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00494-7
- By:
- Publication type:
- Article
MSCsDB: a database of single-cell transcriptomic profiles and in-depth comprehensive analyses of human mesenchymal stem cells.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00496-5
- By:
- Publication type:
- Article
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00495-6
- By:
- Publication type:
- Article
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00483-w
- By:
- Publication type:
- Article
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00493-8
- By:
- Publication type:
- Article
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00485-8
- By:
- Publication type:
- Article
Strain-dependent modifiers exacerbate familial leukemia caused by GATA1-deficiency.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00491-w
- By:
- Publication type:
- Article
The abundance of the short GATA1 isoform affects megakaryocyte differentiation and leukemic predisposition in mice.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00492-9
- By:
- Publication type:
- Article
Challenges and strategies associated with CAR-T cell therapy in blood malignancies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00490-x
- By:
- Publication type:
- Article
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00481-y
- By:
- Publication type:
- Article
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00476-9
- By:
- Publication type:
- Article
Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, p. 1, doi. 10.1186/s40164-024-00489-4
- By:
- Publication type:
- Article
Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, p. 1, doi. 10.1186/s40164-024-00488-5
- By:
- Publication type:
- Article